|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin W, Luo W, Fang W, Wang Y, Wang L, Shen
Q, Liu W and Zhang H: miR-145 expression level in tissue predicts
prognosis of patients with esophageal squamous cell carcinoma.
Pathol Res Pract. 215:1524012019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JG, Chen HZ, Zhu J, Yang YL, Zhang
YH, Huang PX, Chen YS, Zhu CY, Yang LP, Shen K, et al: Cancer
survival in patients from a hospital-based cancer registry, China.
J Cancer. 9:851–860. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rice TW, Ishwaran H, Hofstetter WL,
Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA,
Scott WJ, et al: Esophageal Cancer: Associations With (pN+) Lymph
Node Metastases. Ann Surg. 265:122–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Skotland T, Sagini K, Sandvig K and
Llorente A: An emerging focus on lipids in extracellular vesicles.
Adv Drug Deliv Rev. 159:308–321. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang H, Fu H, Wang B, Zhang X, Mao J, Li
X, Wang M, Sun Z, Qian H and Xu W: Exosomal miR-423-5p targets SUFU
to promote cancer growth and metastasis and serves as a novel
marker for gastric cancer. Mol Carcinog. 57:1223–1236. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumoto Y, Kano M, Akutsu Y, Hanari N,
Hoshino I, Murakami K, Usui A, Suito H, Takahashi M, Otsuka R, et
al: Quantification of plasma exosome is a potential prognostic
marker for esophageal squamous cell carcinoma. Oncol Rep.
36:2535–2543. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsumoto Y, Kano M, Murakami K, Toyozumi
T, Suito H, Takahashi M, Sekino N, Shiraishi T, Kamata T, Ryuzaki
T, et al: Tumor-derived exosomes influence the cell cycle and cell
migration of human esophageal cancer cell lines. Cancer Sci.
111:4348–4358. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang P, Zhou J, Liang Z, Yang Y, Luan S,
Xiao X, Li X, Zhang H, Shang Q, Zeng X and Yuan Y: Immunotherapy
resistance in esophageal cancer: Possible mechanisms and clinical
implications. Front Immunol. 13:9759862022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang K, Toyozumi T, Murakami K, Sakata H,
Kano M, Endo S, Matsumoto Y, Suito H, Takahashi M, Sekino N, et al:
HIF-1α stimulates the progression of oesophageal squamous cell
carcinoma by activating the Wnt/β-catenin signalling pathway. Br J
Cancer. 127:474–487. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berezikov E, Guryev V, van de Belt J,
Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and
computational identification of human microRNA genes. Cell.
120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hemmatzadeh M, Mohammadi H, Karimi M,
Musavishenas MH and Baradaran B: Differential role of microRNAs in
the pathogenesis and treatment of esophageal cancer. Biomed
Pharmacother. 82:509–519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niu Y and Tang G: miR-185-5p targets ROCK2
and inhibits cell migration and invasion of hepatocellular
carcinoma. Oncol Lett. 17:5087–5093. 2019.PubMed/NCBI
|
|
15
|
Liu C, Cai L and Li H: miR-185 regulates
the growth of osteosarcoma cells via targeting hexokinase 2. Mol
Med Rep. 20:2774–2782. 2019.PubMed/NCBI
|
|
16
|
Ostadrahimi S, Abedi Valugerdi M, Hassan
M, Haddad G, Fayaz S, Parvizhamidi M, Mahdian R and Fard Esfahani
P: miR-1266-5p and miR-185-5p promote cell apoptosis in human
prostate cancer cell lines. Asian Pac J Cancer Prev. 19:2305–2311.
2018.PubMed/NCBI
|
|
17
|
Zhang W, Sun Z, Su L, Wang F, Jiang Y, Yu
D, Zhang F, Sun Z and Liang W: miRNA-185 serves as a prognostic
factor and suppresses migration and invasion through Wnt1 in colon
cancer. Eur J Pharmacol. 825:75–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan Z, Jiang H, Wu Y, Xie L, Dai W, Tang H
and Tang S: miR-185 is an independent prognosis factor and
suppresses tumor metastasis in gastric cancer. Mol Cell Biochem.
386:223–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li BX, Yu Q, Shi ZL, Li P and Fu S:
Circulating microRNAs in esophageal squamous cell carcinoma:
Association with locoregional staging and survival. Int J Clin Exp
Med. 8:7241–7250. 2015.PubMed/NCBI
|
|
20
|
Zhao ZT, Zhou W, Liu LY, Lan T, Zhan QM
and Song YM: Molecular mechanism and effect of microRNA185 on
proliferation, migration and invasion of esophageal squamous cell
carcinoma. Zhonghua Yi Xue Za Zhi. 93:1426–1431. 2013.(In Chinese).
PubMed/NCBI
|
|
21
|
Jing R, Chen W, Wang H, Ju S, Cong H, Sun
B, Jin Q, Chu S, Xu L and Cui M: Plasma miR-185 is decreased in
patients with esophageal squamous cell carcinoma and might suppress
tumor migration and invasion by targeting RAGE. Am J Physiol
Gastrointest Liver Physiol. 309:G719–G729. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Japan Esophageal Society: Japanese
classification of esophageal cancer, 11th edition: Part I.
Esophagus. 14:1–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sashiyama H, Shino Y, Kawamata Y, Tomita
Y, Ogawa N, Shimada H, Kobayashi S, Asano T, Ochiai T and Shirasawa
H: Immortalization of human esophageal keratinocytes by E6 and E7
of human papillomavirus type 16. Int J Oncol. 19:97–103.
2001.PubMed/NCBI
|
|
24
|
Jung MK and Mun JY: Sample preparation and
imaging of exosomes by transmission electron microscopy. J Vis Exp.
131:564822018.
|
|
25
|
Takeshita N, Hoshino I, Mori M, Akutsu Y,
Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, et
al: Serum microRNA expression profile: miR-1246 as a novel
diagnostic and prognostic biomarker for oesophageal squamous cell
carcinoma. Br J Cancer. 108:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Talukdar FR, di Pietro M, Secrier M,
Moehler M, Goepfert K, Lima SSC, Pinto LFR, Hendricks D, Parker MI
and Herceg Z: Molecular landscape of esophageal cancer:
Implications for early detection and personalized therapy. Ann N Y
Acad Sci. 1434:342–359. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y: Epidemiology of esophageal
cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Manier S, Liu CJ, Avet-Loiseau H, Park J,
Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, et
al: Prognostic role of circulating exosomal miRNAs in multiple
myeloma. Blood. 129:2429–2436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1568–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer Cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Garofalo M, Di Leva G, Romano G, Nuovo G,
Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P,
et al: miR-221&222 regulate TRAIL resistance and enhance
tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell.
16:498–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y,
Li C, Chong M, Ibrahim T, Mercatali L, et al: miR-126 and miR-126*
repress recruitment of mesenchymal stem cells and inflammatory
monocytes to inhibit breast cancer metastasis. Nat Cell Biol.
15:284–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mao Y, Li L, Liu J, Wang L and Zhou Y:
MiR-495 inhibits esophageal squamous cell carcinoma progression by
targeting Akt1. Oncotarget. 7:51223–51236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao Y, Song Y, Yao L, Song G and Teng C:
Circulating microRNAs: Promising biomarkers involved in several
cancers and other diseases. DNA Cell Biol. 36:77–94. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: MiR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: A novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fan L, Tan B, Li Y, Zhao Q, Yuan H, Liu Y,
Wang D and Zhang Z: Upregulation of miR-185 promotes apoptosis of
the human gastric cancer cell line MGC803. Mol Med Rep.
17:3115–3122. 2018.PubMed/NCBI
|
|
42
|
Değerli E, Torun V and Cansaran-Duman D:
miR-185-5p response to usnic acid suppresses proliferation and
regulating apoptosis in breast cancer cell by targeting Bcl2. Biol
Res. 53:192020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
